KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Inventory Average (2019 - 2025)

Castle Biosciences' Inventory Average history spans 7 years, with the latest figure at $9.5 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 28.54% year-over-year to $9.5 million; the TTM value through Dec 2025 reached $9.5 million, up 28.54%, while the annual FY2025 figure was $9.2 million, 14.38% up from the prior year.
  • Inventory Average for Q4 2025 was $9.5 million at Castle Biosciences, up from $8.5 million in the prior quarter.
  • Across five years, Inventory Average topped out at $9.5 million in Q4 2025 and bottomed at $2.2 million in Q1 2022.
  • The 5-year median for Inventory Average is $5.6 million (2023), against an average of $5.4 million.
  • The largest annual shift saw Inventory Average surged 94.46% in 2023 before it fell 3.87% in 2025.
  • A 5-year view of Inventory Average shows it stood at $2.2 million in 2021, then surged by 77.02% to $3.9 million in 2022, then surged by 76.19% to $6.9 million in 2023, then grew by 7.26% to $7.4 million in 2024, then rose by 28.54% to $9.5 million in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Inventory Average are $9.5 million (Q4 2025), $8.5 million (Q3 2025), and $7.6 million (Q2 2025).